| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/03/2003 | CA2461898A1 Biological control of nanoparticles |
| 04/03/2003 | CA2461864A1 Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries |
| 04/03/2003 | CA2461861A1 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 04/03/2003 | CA2461853A1 Anti-fusion assay |
| 04/03/2003 | CA2461631A1 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules |
| 04/03/2003 | CA2461611A1 Optoinjection methods |
| 04/03/2003 | CA2461563A1 Flavonoids for treatment of diabetes |
| 04/03/2003 | CA2461532A1 Use of isogenic human cancer cells for high-throughput screening and drug discovery |
| 04/03/2003 | CA2461526A1 Aptamers containing sequences of nucleic acids or nucleic acid analogues bound homologously, or in novel complexes |
| 04/03/2003 | CA2461471A1 Antibody and use thereof |
| 04/03/2003 | CA2461454A1 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior |
| 04/03/2003 | CA2461410A1 Dna providing system |
| 04/03/2003 | CA2461372A1 Dna sequences for human angiogenesis genes |
| 04/03/2003 | CA2461357A1 Method for inhibiting the proliferation of hepatic stellate cells with a ligand of the low affinity glucocorticoid binding site (lags) |
| 04/03/2003 | CA2461305A1 Methods of suppressing microglial activation and systemic inflammatory responses |
| 04/03/2003 | CA2461295A1 Vitamin fortification of foodstuffs |
| 04/03/2003 | CA2461290A1 Modulation of stem cells using zinc finger proteins |
| 04/03/2003 | CA2461271A1 Systems, methods and kits for remote genetic analysis and consultation |
| 04/03/2003 | CA2461186A1 Novel screening method using prokineticin receptor |
| 04/03/2003 | CA2461185A1 Method of screening reprogramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs |
| 04/03/2003 | CA2461139A1 Method for producing a normalized gene library from nucleic acid extracts of soil samples and the use thereof |
| 04/03/2003 | CA2461121A1 Multipotent stem cell in the interstitial tissues of skeletal muscle |
| 04/03/2003 | CA2460953A1 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | CA2460803A1 Antibody against metastin and use thereof in diagnosing pregnancy |
| 04/03/2003 | CA2460528A1 Method of attachment of a biomolecule to a solid surface |
| 04/03/2003 | CA2459999A1 Antagonists_and agonists of igf-1 receptor |
| 04/03/2003 | CA2459926A1 Screening and selection methods for statin drug combinations |
| 04/03/2003 | CA2459508A1 Methods of using quantitative lipid metabolome data |
| 04/03/2003 | CA2455117A1 Enzyme phosphorylating ser46 of p53 |
| 04/03/2003 | CA2453985A1 Receptors and membrane-associated proteins |
| 04/03/2003 | CA2424813A1 Two-dimensional quantified imaging method for distinguishing and quantifying poliferating tissue from oncogenic heterometaplasia |
| 04/02/2003 | EP1298441A2 A cyanide-free lytic reagent composition and method for hemoglobin and cell analysis |
| 04/02/2003 | EP1298439A1 Method for screening mch receptor antagonist/agonist |
| 04/02/2003 | EP1298438A1 Insoluble carrier particle nephelometric immunoassay reagent |
| 04/02/2003 | EP1298437A1 Colorimetric test device with reduced error |
| 04/02/2003 | EP1298436A2 Beta-amyloid peptide (BAP) release inhibitor compounds for treating BAP-related diseases and methods for their identification |
| 04/02/2003 | EP1298435A2 Assay for compounds affecting invertebrate cell secretory pathways |
| 04/02/2003 | EP1298434A1 Method of screening for new drugs with androgen-like characteristics |
| 04/02/2003 | EP1298433A1 Device and method for the generation of arrays of substance mixtures by diffusion |
| 04/02/2003 | EP1298432A1 Methods for characterising gas-tight cement slurries |
| 04/02/2003 | EP1298431A2 High-precision method and apparatus for evaluating creep damage |
| 04/02/2003 | EP1298430A2 Gas sensor with error compensation |
| 04/02/2003 | EP1298428A1 Device for inspecting liquid-filled transparent containers |
| 04/02/2003 | EP1298426A1 Sampling probe for melts |
| 04/02/2003 | EP1298302A1 Exhaust gas purifying method for lean burn engines |
| 04/02/2003 | EP1298223A2 Methods related to the A-C repeat Z-sequence upstream from the aldose reductase gene |
| 04/02/2003 | EP1298222A2 Methods to evaluate rice palatability and to select rice with platable traits through analysis of half grain of unhulled/unpulische rice |
| 04/02/2003 | EP1298219A1 Method of assaying the function of fc fragment of antibody |
| 04/02/2003 | EP1298211A2 Polynucleotide segment of HPV16 Genome |
| 04/02/2003 | EP1298203A2 Diagnosis and treatment of autoimmune diseases |
| 04/02/2003 | EP1298197A1 Method and apparatus for treating mash |
| 04/02/2003 | EP1298144A2 Murine monoclonal anti-idiotype antibody 3H1 |
| 04/02/2003 | EP1298069A2 Device for use in monitoring swab technique |
| 04/02/2003 | EP1297851A1 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
| 04/02/2003 | EP1297847A2 Anti-CD18 antibodies in stroke |
| 04/02/2003 | EP1297841A1 Pancreatic langerhans beta cell proliferation promoter and apoptosis inhibitor, and screening of candidate compounds for the e drugs |
| 04/02/2003 | EP1297744A2 A device for separating milk from dairy animals |
| 04/02/2003 | EP1297743A2 A device for separating milk from a dairy animal |
| 04/02/2003 | EP1297742A2 A method of collecting measurement data during automatically milking an animal |
| 04/02/2003 | EP1297741A2 A device for milking animals |
| 04/02/2003 | EP1297484A2 Method and apparatus for sequence analysis |
| 04/02/2003 | EP1297342A1 Diagnostic method for alzheimer's disease based on holo-transcobalamin ii |
| 04/02/2003 | EP1297341A2 Methods of identifying gaba b? receptor subtype-specific agonists |
| 04/02/2003 | EP1297340A2 Low fluorescence nylon/glass composites for microdagnostics |
| 04/02/2003 | EP1297339A2 Support plate and method for the carrying out of functional tests |
| 04/02/2003 | EP1297338A2 Microarrays for performing proteomic analyses |
| 04/02/2003 | EP1297337A2 Method for increasing luminescence assay sensitivity |
| 04/02/2003 | EP1297336A2 Immunoassay and immunoassay apparatus |
| 04/02/2003 | EP1297335A2 Process for the measurement of dinophysistoxin and of yessotoxin |
| 04/02/2003 | EP1297334A1 Flow cytometry-based hematology system |
| 04/02/2003 | EP1297333A2 Ingestibles possessing intrinsic color change |
| 04/02/2003 | EP1297319A1 Gas cell adapted for carbon dioxide |
| 04/02/2003 | EP1297317A1 Quasi-static viscometer |
| 04/02/2003 | EP1297187A2 Method for the detection of influenza a/b viruses |
| 04/02/2003 | EP1297186A1 Method of screening for chemotherapeutic treatments for cancer |
| 04/02/2003 | EP1297185A2 Diagnosis of diseases associated with signal transduction |
| 04/02/2003 | EP1297183A2 Method for identifying substances which are suitable to be used for treating virus infections |
| 04/02/2003 | EP1297182A2 Diagnosis of diseases associated with cell signalling |
| 04/02/2003 | EP1297180A2 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 04/02/2003 | EP1297175A2 Methods and compounds for modulating nuclear receptor coactivator binding |
| 04/02/2003 | EP1297174A2 Interaction of tbx2 and the arf promoter in cell cycle regulator assays |
| 04/02/2003 | EP1297173A1 Personal breast cancer indicator |
| 04/02/2003 | EP1297147A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 04/02/2003 | EP1297142A2 Dual specificity antibodies and methods of making and using |
| 04/02/2003 | EP1297139A2 G-protein coupled receptor org10 |
| 04/02/2003 | EP1297138A2 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof |
| 04/02/2003 | EP1297137A2 Gp286 nucleic acids and polypeptides |
| 04/02/2003 | EP1297136A2 Full length human hcn1 ih channel subunit and variants |
| 04/02/2003 | EP1297135A2 Pd-l2 molecules: novel pd-1 ligands and uses therefor |
| 04/02/2003 | EP1297133A2 Gp354 nucleic acids and polypeptides |
| 04/02/2003 | EP1297132A1 A novel app mutation associated with an unusual alzheimer's disease pathology |
| 04/02/2003 | EP1297130A2 G-protein coupled receptors |
| 04/02/2003 | EP1297129A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 04/02/2003 | EP1297128A2 G-protein coupled receptors |
| 04/02/2003 | EP1297114A1 NUCLEIC ACID MOLECULES ENCODING A PROTEIN INTERACTING WITH Ser/Thr KINASE Akt |
| 04/02/2003 | EP1297110A1 Attenuated bovine respiratory syncytial virus |
| 04/02/2003 | EP1297108A2 Cell lines and cell-based assays for identification of androgen receptor modulators |
| 04/02/2003 | EP1297026A1 Polymers for binding of phenols |
| 04/02/2003 | EP1297017A2 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 04/02/2003 | EP1297015A1 Structure based drug design method to identify compounds that bind to cd81, a cell receptor for hepatitis-c |